COMBI-d study
Read more about the COMBI-d study, such as the study design and the most important results.
The patient population consisted of 423 patients with unresectable (Stage IIIC) or metastatic (...
Twitter Linkedin Facebook Pinterest Google plusCOMBI-v study
Read more about the COMBI-v study, such as the study design and the most important results.
The patient population consisted of 704 patients with unresectable (Stage IIIC) or metastatic (...
Twitter Linkedin Facebook Pinterest Google plusIndications - Cosentyx PsA
Cosentyx (generic name: secukinumab) is a medication used to treat several autoimmune conditions. Here are the key indications for Cosentyx:
1. Plaque Psoriasis:
For adults with moderate to severe...
Twitter Linkedin Facebook Pinterest Google plusSafety profile
Dosing